Allied World Assurance (AWH) to Offer Common Stock
- S&P, Nasdaq futures rise as JPMorgan, Goldman set to kick off earnings season
- JPMorgan (JPM) Tops Q1 EPS by $1.40, Revenues Beat
- Coinbase (COIN) direct listing IPO reference price set at $250
- Oil maintains upward momentum despite fresh coronavirus fears
- Dollar nurses losses as 'mean reversion' trade widens
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
Aspira Women’s Health Inc. (Nasdaq: AWH) announced it has commenced an underwritten public offering of shares of its common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Aspira is expected to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock being offered at the public offering price, less underwriting discounts and commissions. All of the shares will be offered by Aspira.
William Blair & Company, L.L.C. and Truist Securities, Inc. are acting as joint book-running managers for the offering, and Brookline Capital Markets, a division of Arcadia Securities, LLC, is acting as co-manager for the offering.
Aspira intends to use the net proceeds from the offering for sales and marketing, working capital and other general corporate purposes, including investing in additional key strategic hires, product portfolio expansion and research and development. Aspira may also use a portion of the net proceeds from the offering to acquire or invest in complimentary businesses, technologies, product candidates or other intellectual property, although Aspira has no present commitments or agreements to do so.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wex, Inc. (WEX) Reports Acquisition of benefitexpress
- Biggest SPAC Deal Ever: Grab To Go Public in a $40 Billion Merger With Altimeter (AGC), Backed by Fidelity and BlackRock
- From Harvard to Nasdaq listing: Grab CEO's ride to world's biggest SPAC deal